U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 1 to 100 of 224

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh38:
Chr16:28486250-28486550
CLN3Neuronal ceroid lipofuscinosis 3Pathogenic
(Aug 24, 2023)
criteria provided, single submitter
2.
GRCh37:
Chr16:28499002-28499003
GRCh38:
Chr16:28487681-28487682
CLN3L119fs, L41fs, L65fs, L95fsNeuronal ceroid lipofuscinosis 3Pathogenic
(Feb 17, 2023)
criteria provided, single submitter
3.
CLN3Neuronal ceroid lipofuscinosis 3Pathogenic
(Sep 5, 2022)
criteria provided, single submitter
4.
GRCh37:
Chr16:28499930
GRCh38:
Chr16:28488609
CLN3A19E, C38*, C92*Neuronal ceroid lipofuscinosis 3Likely pathogenic
(Mar 6, 2022)
criteria provided, single submitter
5.
GRCh37:
Chr16:28497904
GRCh38:
Chr16:28486583
CLN3Y122*, Y152*, Y176*, Y76*, Y98*Neuronal ceroid lipofuscinosis 3Likely pathogenic
(Dec 31, 2021)
criteria provided, single submitter
6.
GRCh37:
Chr16:28493855
GRCh38:
Chr16:28482534
CLN3W183fs, W205fs, W229fs, W259fs, W283fsNeuronal ceroid lipofuscinosis 3Likely pathogenic
(Dec 30, 2021)
criteria provided, single submitter
7.
GRCh37:
Chr16:28493444
GRCh38:
Chr16:28482123
CLN3W246*, W268*, W292*, W322*, W346*Neuronal ceroid lipofuscinosis 3Likely pathogenic
(May 21, 2022)
criteria provided, single submitter
8.
GRCh37:
Chr16:28493852
GRCh38:
Chr16:28482531
CLN3Y184*, Y206*, Y230*, Y260*, Y284*Neuronal ceroid lipofuscinosis 3Likely pathogenic
(Mar 15, 2022)
criteria provided, single submitter
9.
GRCh37:
Chr16:28497735
GRCh38:
Chr16:28486414
CLN3Q104*, Q126*, Q150*, Q180*, Q204*Neuronal ceroid lipofuscinosis 3Likely pathogenic
(Mar 14, 2022)
criteria provided, single submitter
10.
GRCh37:
Chr16:28498854-28498855
GRCh38:
Chr16:28487533-28487534
CLN3V104fs, V128fs, V28fs, V50fs, V74fsNeuronal ceroid lipofuscinosis 3Pathogenic
(May 4, 2022)
criteria provided, single submitter
11.
GRCh37:
Chr16:28497807
GRCh38:
Chr16:28486486
CLN3V156M, V180M, V126M, V80M, V102MNeuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis 3Uncertain significance
(Oct 13, 2022)
criteria provided, multiple submitters, no conflicts
12.
GRCh37:
Chr16:28497920
GRCh38:
Chr16:28486599
CLN3S117F, S147F, S171F, S71F, S93FRetinitis pigmentosa, Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis 3
Conflicting interpretations of pathogenicity
(May 27, 2022)
criteria provided, conflicting interpretations
13.
GRCh37:
Chr16:28500686
GRCh38:
Chr16:28489365
CLN3N49KNeuronal ceroid lipofuscinosis 3, Neuronal ceroid lipofuscinosisUncertain significance
(Aug 9, 2022)
criteria provided, multiple submitters, no conflicts
14.
GRCh37:
Chr16:28499991
GRCh38:
Chr16:28488670
CLN3Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis 3Likely benign
(Jun 26, 2022)
criteria provided, multiple submitters, no conflicts
15.
GRCh37:
Chr16:28499040
GRCh38:
Chr16:28487719
CLN3L106H, L28H, L52H, L82HNeuronal ceroid lipofuscinosis 3Uncertain significance
(Apr 8, 2021)
criteria provided, single submitter
16.
GRCh37:
Chr16:28494000
GRCh38:
Chr16:28482679
CLN3Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis 3Conflicting interpretations of pathogenicity
(Sep 1, 2022)
criteria provided, conflicting interpretations
17.
GRCh37:
Chr16:28498858
GRCh38:
Chr16:28487537
CLN3R103W, R127W, R27W, R49W, R73WNeuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis 3Uncertain significance
(Oct 17, 2022)
criteria provided, multiple submitters, no conflicts
18.
GRCh37:
Chr16:28489128
GRCh38:
Chr16:28477807
CLN3L276fs, L298fs, L322fs, L352fs, L376fsNeuronal ceroid lipofuscinosis 3Likely pathogenic
(Jan 24, 2019)
no assertion criteria provided
19.
GRCh37:
Chr16:28493648
GRCh38:
Chr16:28482327
CLN3W221*, W243*, W267*, W297*, W321*Neuronal ceroid lipofuscinosis 3Likely pathogenic
(Mar 16, 2020)
criteria provided, single submitter
20.
GRCh37:
Chr16:28500658
GRCh38:
Chr16:28489337
CLN3A5T, A59TNeuronal ceroid lipofuscinosis 3, Neuronal ceroid lipofuscinosis, not provided
Conflicting interpretations of pathogenicity
(Nov 3, 2022)
criteria provided, conflicting interpretations
21.
GRCh37:
Chr16:28497668-28497972
CLN3Neuronal ceroid lipofuscinosis 3Pathogenic
(Apr 16, 2020)
no assertion criteria provided
22.
GRCh37:
Chr16:28488779
GRCh38:
Chr16:28477458
CLN3Neuronal ceroid lipofuscinosis 3Uncertain significance
(Mar 23, 2018)
criteria provided, single submitter
23.
GRCh37:
Chr16:28488726
GRCh38:
Chr16:28477405
CLN3Neuronal ceroid lipofuscinosis 3Uncertain significance
(Apr 27, 2017)
criteria provided, single submitter
24.
GRCh37:
Chr16:28497780
GRCh38:
Chr16:28486459
CLN3G135W, G165W, G189W, G89W, G111WNeuronal ceroid lipofuscinosis 3Uncertain significance
(May 22, 2022)
criteria provided, multiple submitters, no conflicts
25.
GRCh37:
Chr16:28488650
GRCh38:
Chr16:28477329
CLN3Neuronal ceroid lipofuscinosis 3Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
26.
GRCh37:
Chr16:28503628
GRCh38:
Chr16:28492307
CLN3Neuronal ceroid lipofuscinosis 3Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
27.
GRCh37:
Chr16:28503543
GRCh38:
Chr16:28492222
CLN3Neuronal ceroid lipofuscinosis 3Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
28.
GRCh37:
Chr16:28503474
GRCh38:
Chr16:28492153
CLN3Neuronal ceroid lipofuscinosis 3Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
29.
GRCh37:
Chr16:28495358
GRCh38:
Chr16:28484037
CLN3Neuronal ceroid lipofuscinosis, not provided, Neuronal ceroid lipofuscinosis 3
Conflicting interpretations of pathogenicity
(Nov 2, 2022)
criteria provided, conflicting interpretations
30.
GRCh37:
Chr16:28493836
GRCh38:
Chr16:28482515
CLN3V290I, V190I, V266I, V212I, V236INeuronal ceroid lipofuscinosis 3Uncertain significance
(Apr 28, 2017)
criteria provided, single submitter
31.
GRCh37:
Chr16:28500627
GRCh38:
Chr16:28489306
CLN3S15W, S69WNeuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis 3Uncertain significance
(Feb 3, 2022)
criteria provided, multiple submitters, no conflicts
32.
GRCh37:
Chr16:28489171
GRCh38:
Chr16:28477850
CLN3D284N, D362N, D262N, D308N, D338NNeuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis 3Uncertain significance
(Sep 20, 2022)
criteria provided, multiple submitters, no conflicts
33.
GRCh37:
Chr16:28489136
GRCh38:
Chr16:28477815
CLN3Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis 3Conflicting interpretations of pathogenicity
(Aug 31, 2022)
criteria provided, conflicting interpretations
34.
GRCh37:
Chr16:28495366
GRCh38:
Chr16:28484045
CLN3Q251*, Q151*, Q173*, Q227*, Q197*Neuronal ceroid lipofuscinosis, Retinal dystrophy, Neuronal ceroid lipofuscinosis 3
Pathogenic/Likely pathogenic
(Nov 13, 2021)
criteria provided, multiple submitters, no conflicts
35.
GRCh37:
Chr16:28497968
GRCh38:
Chr16:28486647
CLN3V101G, V55G, V131G, V77G, V155GNeuronal ceroid lipofuscinosis 3, Neuronal ceroid lipofuscinosis, not provided
Uncertain significance
(Oct 18, 2022)
criteria provided, multiple submitters, no conflicts
36.
GRCh37:
Chr16:28495325
GRCh38:
Chr16:28484004
CLN3Neuronal ceroid lipofuscinosis 3, Neuronal ceroid lipofuscinosisPathogenic/Likely pathogenic
(Dec 15, 2019)
criteria provided, multiple submitters, no conflicts
37.
GRCh37:
Chr16:28495335
GRCh38:
Chr16:28484014
CLN3S161L, S207L, S237L, S183L, S261LInborn genetic diseases, Neuronal ceroid lipofuscinosis 3, not provided,
Neuronal ceroid lipofuscinosis
Uncertain significance
(Sep 29, 2022)
criteria provided, multiple submitters, no conflicts
38.
GRCh37:
Chr16:28497668-28497971
CLN3Neuronal ceroid lipofuscinosis 3Pathogenic
(Jun 11, 2019)
criteria provided, single submitter
39.
GRCh37:
Chr16:28500715
GRCh38:
Chr16:28489394
CLN3Neuronal ceroid lipofuscinosis, not provided, Neuronal ceroid lipofuscinosis 3
Conflicting interpretations of pathogenicity
(Nov 1, 2022)
criteria provided, conflicting interpretations
40.
GRCh37:
Chr16:28497280-28498401
GRCh38:
Chr16:28485959-28487080
CLN3Neuronal ceroid lipofuscinosis 3Pathogenic
(Jan 1, 2015)
criteria provided, single submitter
41.
GRCh37:
Chr16:28491981-28494795
GRCh38:
Chr16:28480660-28483474
CLN3Neuronal ceroid lipofuscinosis 3Pathogenic
(Jan 8, 2018)
criteria provided, single submitter
42.
GRCh37:
Chr16:28488951
GRCh38:
Chr16:28477630
CLN3S401R, S377R, S301R, S323R, S347RInborn genetic diseases, Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis 3
Uncertain significance
(Jul 26, 2022)
criteria provided, multiple submitters, no conflicts
43.
GRCh37:
Chr16:28488869
GRCh38:
Chr16:28477548
CLN3P429S, P375S, P329S, P351S, P405Snot provided, Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis 3
Uncertain significance
(Aug 23, 2022)
criteria provided, multiple submitters, no conflicts
44.
GRCh37:
Chr16:28488914
GRCh38:
Chr16:28477593
CLN3I414V, I314V, I336V, I360V, I390VNeuronal ceroid lipofuscinosis, not provided, Neuronal ceroid lipofuscinosis 3
Uncertain significance
(Sep 1, 2022)
criteria provided, multiple submitters, no conflicts
45.
GRCh37:
Chr16:28497701
GRCh38:
Chr16:28486380
CLN3S215Y, S137Y, S115Y, S161Y, S191YNeuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis 3Uncertain significance
(Sep 7, 2022)
criteria provided, multiple submitters, no conflicts
46.
GRCh37:
Chr16:28502884
GRCh38:
Chr16:28491563
CLN3Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis 3Uncertain significance
(May 21, 2022)
criteria provided, multiple submitters, no conflicts
47.
GRCh37:
Chr16:28503034
GRCh38:
Chr16:28491713
CLN3Neuronal ceroid lipofuscinosis 3Likely pathogenic
(May 29, 2018)
criteria provided, single submitter
48.
GRCh37:
Chr16:28493562-28493563
GRCh38:
Chr16:28482241-28482242
CLN3Neuronal ceroid lipofuscinosis 3Likely benign
(Apr 6, 2018)
criteria provided, single submitter
49.
GRCh37:
Chr16:28499064
GRCh38:
Chr16:28487743
CLN3Neuronal ceroid lipofuscinosis 3Likely pathogenic
(Feb 6, 2018)
criteria provided, single submitter
50.
GRCh37:
Chr16:28502882
GRCh38:
Chr16:28491561
CLN3Neuronal ceroid lipofuscinosis 3, Neuronal ceroid lipofuscinosisConflicting interpretations of pathogenicity
(Jun 13, 2022)
criteria provided, conflicting interpretations
51.
GRCh37:
Chr16:28495326
GRCh38:
Chr16:28484005
CLN3Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis 3Pathogenic/Likely pathogenic
(Feb 10, 2022)
criteria provided, multiple submitters, no conflicts
52.
GRCh37:
Chr16:28499984
GRCh38:
Chr16:28488663
CLN3Neuronal ceroid lipofuscinosis 3Likely pathogenic
(Jun 20, 2017)
criteria provided, single submitter
53.
GRCh37:
Chr16:28502802
GRCh38:
Chr16:28491481
CLN3Neuronal ceroid lipofuscinosis 3Likely pathogenic
(May 9, 2017)
criteria provided, single submitter
54.
GRCh37:
Chr16:28500637-28500638
GRCh38:
Chr16:28489316-28489317
CLN3K66fs, K12fsNeuronal ceroid lipofuscinosis 3Likely pathogenic
(Feb 7, 2017)
criteria provided, single submitter
55.
GRCh37:
Chr16:28489139
GRCh38:
Chr16:28477818
CLN3Y372*, Y318*, Y272*, Y294*, Y348*Neuronal ceroid lipofuscinosis 3Likely pathogenic
(Jan 31, 2017)
criteria provided, single submitter
56.
GRCh37:
Chr16:28503080
GRCh38:
Chr16:28491759
CLN3M1VNeuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis 3Pathogenic/Likely pathogenic
(Aug 10, 2022)
criteria provided, multiple submitters, no conflicts
57.
GRCh37:
Chr16:28489187-28489188
GRCh38:
Chr16:28477866-28477867
CLN3V303fs, V333fs, V257fs, V279fs, V357fsNeuronal ceroid lipofuscinosis 3Likely pathogenic
(Jan 6, 2017)
criteria provided, single submitter
58.
GRCh37:
Chr16:28493521
GRCh38:
Chr16:28482200
CLN3Neuronal ceroid lipofuscinosis 3Likely pathogenic
(Dec 29, 2017)
criteria provided, single submitter
59.
GRCh37:
Chr16:28495369
GRCh38:
Chr16:28484048
CLN3R250W, R172W, R150W, R226W, R196WNeuronal ceroid lipofuscinosis 3, Neuronal ceroid lipofuscinosisUncertain significance
(Aug 21, 2022)
criteria provided, multiple submitters, no conflicts
60.
GRCh37:
Chr16:28497730
GRCh38:
Chr16:28486409
CLN3not specified, Neuronal ceroid lipofuscinosisLikely benign
(Oct 20, 2022)
criteria provided, multiple submitters, no conflicts
61.
GRCh37:
Chr16:28499048
GRCh38:
Chr16:28487727
CLN3not specified, Neuronal ceroid lipofuscinosis 3, Neuronal ceroid lipofuscinosis
Likely benign
(Oct 4, 2022)
criteria provided, multiple submitters, no conflicts
62.
GRCh37:
Chr16:28493834
GRCh38:
Chr16:28482513
CLN3not specified, Neuronal ceroid lipofuscinosisLikely benign
(Feb 16, 2022)
criteria provided, multiple submitters, no conflicts
63.
GRCh37:
Chr16:28489168
GRCh38:
Chr16:28477847
CLN3V363M, V263M, V309M, V339M, V285MInborn genetic diseases, not provided, Neuronal ceroid lipofuscinosis 3,
Neuronal ceroid lipofuscinosis
Uncertain significance
(Oct 7, 2022)
criteria provided, multiple submitters, no conflicts
64.
GRCh37:
Chr16:28495346
GRCh38:
Chr16:28484025
CLN3E257D, E157D, E179D, E203D, E233Dnot provided, Neuronal ceroid lipofuscinosis 3, Neuronal ceroid lipofuscinosis
Uncertain significance
(Sep 5, 2021)
criteria provided, multiple submitters, no conflicts
65.
GRCh37:
Chr16:28500681
GRCh38:
Chr16:28489360
CLN3S51FNeuronal ceroid lipofuscinosis 3, not provided, Neuronal ceroid lipofuscinosis
Uncertain significance
(Jul 31, 2022)
criteria provided, multiple submitters, no conflicts
66.
GRCh37:
Chr16:28497775-28497776
GRCh38:
Chr16:28486454-28486455
CLN3A113fs, A91fs, A191fs, A137fs, A167fsNeuronal ceroid lipofuscinosis, not provided, Neuronal ceroid lipofuscinosis 3
Pathogenic
(Sep 2, 2021)
criteria provided, multiple submitters, no conflicts
67.
GRCh37:
Chr16:28498790
GRCh38:
Chr16:28487469
CLN3not specified, Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis 3
Conflicting interpretations of pathogenicity
(Sep 1, 2022)
criteria provided, conflicting interpretations
68.
GRCh37:
Chr16:28500611
GRCh38:
Chr16:28489290
CLN3M1TNeuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis 3, not provided
Conflicting interpretations of pathogenicity
(Aug 5, 2022)
criteria provided, conflicting interpretations
69.
GRCh37:
Chr16:28499967
GRCh38:
Chr16:28488646
CLN3T80M, R7C, T26MNeuronal ceroid lipofuscinosis 3, not provided, Neuronal ceroid lipofuscinosis
Uncertain significance
(Sep 7, 2022)
criteria provided, multiple submitters, no conflicts
70.
GRCh37:
Chr16:28497284-28498250
GRCh38:
Chr16:28485963-28486929
CLN3Neuronal ceroid lipofuscinosis 3Pathogenic
(Jun 6, 2015)
criteria provided, single submitter
71.
GRCh37:
Chr16:28493851
GRCh38:
Chr16:28482530
CLN3I285V, I207V, I261V, I185V, I231VRetinal dystrophy, Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis 3
Uncertain significance
(Mar 11, 2022)
criteria provided, multiple submitters, no conflicts
72.
GRCh37:
Chr16:28499916
GRCh38:
Chr16:28488595
CLN3T97M, T43M, R24WNeuronal ceroid lipofuscinosis 3, Inborn genetic diseases, not specified,
Neuronal ceroid lipofuscinosis
Uncertain significance
(Aug 23, 2022)
criteria provided, multiple submitters, no conflicts
73.
GRCh37:
Chr16:28499038
GRCh38:
Chr16:28487717
CLN3P107S, P29S, P83S, P53SNeuronal ceroid lipofuscinosis 3, not specified, Neuronal ceroid lipofuscinosis
Uncertain significance
(Oct 18, 2022)
criteria provided, multiple submitters, no conflicts
74.
GRCh37:
Chr16:28503049
GRCh38:
Chr16:28491728
CLN3F11SNeuronal ceroid lipofuscinosis 3, not provided, Neuronal ceroid lipofuscinosis
Uncertain significance
(Jul 14, 2022)
criteria provided, multiple submitters, no conflicts
75.
GRCh37:
Chr16:28489135
GRCh38:
Chr16:28477814
CLN3V374I, V274I, V296I, V350I, V320IInborn genetic diseases, not provided, Neuronal ceroid lipofuscinosis 3,
Neuronal ceroid lipofuscinosis
Uncertain significance
(Jul 15, 2022)
criteria provided, multiple submitters, no conflicts
76.
GRCh37:
Chr16:28497974
GRCh38:
Chr16:28486653
CLN3Neuronal ceroid lipofuscinosis 3, not provided, Neuronal ceroid lipofuscinosis
Conflicting interpretations of pathogenicity
(Oct 26, 2022)
criteria provided, conflicting interpretations
77.
GRCh37:
Chr16:28493470
GRCh38:
Chr16:28482149
CLN3R338C, R284C, R238C, R260C, R314CInborn genetic diseases, Neuronal ceroid lipofuscinosis, not provided,
Neuronal ceroid lipofuscinosis 3
Uncertain significance
(Jul 19, 2022)
criteria provided, multiple submitters, no conflicts
78.
GRCh37:
Chr16:28488920
GRCh38:
Chr16:28477599
CLN3T412A, T388A, T334A, T312A, T358Anot provided, Neuronal ceroid lipofuscinosis 3, Neuronal ceroid lipofuscinosis
Uncertain significance
(Mar 29, 2022)
criteria provided, multiple submitters, no conflicts
79.
GRCh37:
Chr16:28503081
GRCh38:
Chr16:28491760
CLN3Inborn genetic diseases, not provided, Neuronal ceroid lipofuscinosis 3
Uncertain significance
(Sep 5, 2021)
criteria provided, multiple submitters, no conflicts
80.
GRCh37:
Chr16:28495333
GRCh38:
Chr16:28484012
CLN3K262*, K184*, K162*, K238*, K208*not provided, Neuronal ceroid lipofuscinosis 3Pathogenic
(Mar 22, 2022)
criteria provided, multiple submitters, no conflicts
81.
GRCh37:
Chr16:28493672
GRCh38:
Chr16:28482351
CLN3L313P, L259P, L213P, L235P, L289PNeuronal ceroid lipofuscinosis 3, not provided, Neuronal ceroid lipofuscinosis
Uncertain significance
(Oct 17, 2022)
criteria provided, multiple submitters, no conflicts
82.
GRCh37:
Chr16:28497974
GRCh38:
Chr16:28486653
CLN3not provided, Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis 3
Uncertain significance
(Oct 17, 2022)
criteria provided, multiple submitters, no conflicts
83.
GRCh37:
Chr16:28488941
GRCh38:
Chr16:28477620
CLN3R405W, R351W, R305W, R327W, R381Wnot provided, Retinitis pigmentosa, Neuronal ceroid lipofuscinosis,
Neuronal ceroid lipofuscinosis 3, Retinal dystrophy
Conflicting interpretations of pathogenicity
(Jul 24, 2023)
criteria provided, conflicting interpretations
84.
GRCh37:
Chr16:28499968
GRCh38:
Chr16:28488647
CLN3T80S, T26S, Q6HNeuronal ceroid lipofuscinosis 3, Neuronal ceroid lipofuscinosis, not provided,
Inborn genetic diseases
Conflicting interpretations of pathogenicity
(Oct 17, 2022)
criteria provided, conflicting interpretations
85.
GRCh37:
Chr16:28493970
GRCh38:
Chr16:28482649
CLN3R272W, R172W, R248W, R194W, R218Wnot provided, Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis 3
Uncertain significance
(Sep 13, 2022)
criteria provided, multiple submitters, no conflicts
86.
GRCh37:
Chr16:28502800
GRCh38:
Chr16:28491479
CLN3Neuronal ceroid lipofuscinosis 3, not specified, Neuronal ceroid lipofuscinosis
Conflicting interpretations of pathogenicity
(May 27, 2022)
criteria provided, conflicting interpretations
87.
GRCh37:
Chr16:28493469
GRCh38:
Chr16:28482148
CLN3R338H, R238H, R314H, R260H, R284HNeuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis 3, not specified
Uncertain significance
(Aug 20, 2022)
criteria provided, multiple submitters, no conflicts
88.
GRCh37:
Chr16:28493994
GRCh38:
Chr16:28482673
CLN3Neuronal ceroid lipofuscinosis 3Likely pathogenic
(Oct 12, 2016)
criteria provided, single submitter
89.
GRCh37:
Chr16:28497667
GRCh38:
Chr16:28486346
CLN3Neuronal ceroid lipofuscinosis 3Likely pathogenic
(Oct 19, 2016)
criteria provided, single submitter
90.
GRCh37:
Chr16:28499924-28499925
GRCh38:
Chr16:28488603-28488604
CLN3S40fs, L21fs, S94fsNeuronal ceroid lipofuscinosis 3Likely pathogenic
(Sep 6, 2016)
criteria provided, single submitter
91.
GRCh37:
Chr16:28503079
GRCh38:
Chr16:28491758
CLN3M1TNeuronal ceroid lipofuscinosis 3Likely pathogenic
(Aug 29, 2016)
criteria provided, single submitter
92.
GRCh37:
Chr16:28489196
GRCh38:
Chr16:28477875
CLN3C353*, C253*, C299*, C329*, C275*Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis 3Pathogenic/Likely pathogenic
(May 28, 2019)
criteria provided, multiple submitters, no conflicts
93.
GRCh37:
Chr16:28493520
GRCh38:
Chr16:28482199
CLN3Neuronal ceroid lipofuscinosis 3, Neuronal ceroid lipofuscinosisLikely pathogenic
(Jun 29, 2021)
criteria provided, multiple submitters, no conflicts
94.
GRCh37:
Chr16:28493796
GRCh38:
Chr16:28482475
CLN3not provided, Neuronal ceroid lipofuscinosisPathogenic/Likely pathogenic
(Aug 19, 2022)
criteria provided, multiple submitters, no conflicts
95.
GRCh37:
Chr16:28503034
GRCh38:
Chr16:28491713
CLN3Neuronal ceroid lipofuscinosis 3, Neuronal ceroid lipofuscinosisLikely pathogenic
(May 30, 2022)
criteria provided, multiple submitters, no conflicts
96.
GRCh37:
Chr16:28495433-28495434
GRCh38:
Chr16:28484112-28484113
CLN3L152fs, L206fs, L230fs, L176fs, L130fsNeuronal ceroid lipofuscinosis 3Likely pathogenic
(Dec 21, 2015)
criteria provided, single submitter
97.
GRCh37:
Chr16:28493647
GRCh38:
Chr16:28482326
CLN3Neuronal ceroid lipofuscinosis 3Likely pathogenic
(Nov 25, 2015)
criteria provided, single submitter
98.
GRCh37:
Chr16:28503528
GRCh38:
Chr16:28492207
CLN3Neuronal ceroid lipofuscinosis 3, Neuronal Ceroid-Lipofuscinosis, Dominant/Recessive, not provided
Conflicting interpretations of pathogenicity
(Jul 7, 2018)
criteria provided, conflicting interpretations
99.
GRCh37:
Chr16:28503482
GRCh38:
Chr16:28492161
CLN3Neuronal ceroid lipofuscinosis 3, Neuronal Ceroid-Lipofuscinosis, Dominant/RecessiveUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
100.
GRCh37:
Chr16:28503393
GRCh38:
Chr16:28492072
CLN3Neuronal Ceroid-Lipofuscinosis, Dominant/Recessive, not provided, Neuronal ceroid lipofuscinosis 3
Conflicting interpretations of pathogenicity
(Jun 29, 2018)
criteria provided, conflicting interpretations
Format
Items per page
Sort by
Choose Destination